Suppression of plasminogen activator inhibitor 1 (PAI-1) activity levels in rats by monoclonal antibodies

Fibrinolysis and Proteolysis

Volumn 12, Issue 6, 1998, Pages 335-339

  Ngo, T H ^a   Declerck, P J ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Laboratory for Pharmaceutical Biology and Phytopharmacology   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; MONOCLONAL ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; EXPERIMENTAL MODEL; FIBRINOLYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; RAT; THROMBOGENESIS; THROMBOSIS;

EID: 0032418252     PISSN: 13690191     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(98)80390-1     Document Type: Article

References (21)

1. Declerck PJ, Juhan-Vague I, Felez J, Wiman B. Pathophysiology of fibrinolysis. J Int Med 1994; 236: 425-432.
2. Van Meijer M, Pannekoek H. Structure of plasminogen activator inhibitor 1 (PAI-1) and its function in fibrinolysis: an update. Fibrinolysis 1995; 9: 263-276.
3. Abrahamsson T, Nerme V, Strömqvist M, Åkerblom B, Legnehed A, Pettersson K, Eriksson WA. Anti-thrombotic effect of a PAI-1 inhibitor in rats given endotoxin. Thromb Haemostas 1996; 75: 118-126.
4. Levi M, Biemond BJ, van Zonneveld AJ, ten Gate JW0, Pannekoek H. Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis. Circulation 1992; 85: 305-312.
5. Biemond BJ, Levi M, Coronel R, Janse MJ, ten Gate JW, Pannekoek H. Thrombolysis and reocclusion in experimental jugular vein and coronary artery thrombosis. Effects of a plasminogen activator inhibitor type 1 neutralizing monoclonal antibody. Circulation 1995; 91: 1175-1181.
6. Charlton PA, Faint RW, Bent F et al. Evaluation of a low molecular weight modulator of human plasminogen activator inhibitor-1 activity. Thromb Haemostas 1996; 75: 808-815.
7. Pawlowska Z, Pluskota E, Chabielska E et al. Phosphorothioate oligodeoxyribonucleotides antisense to PAI-1 mRNA increase fibrinolysis and modify experimental thrombosis in rats. Thromb Haemostas 1998; 79: 348-353.
8. Debrock S, Sironi L, Declerck PJ, Cloning of a single-chain variable fragment (scFv) switching active plasminogen activator inhibitor-1 to substrate. Gene 1997; 189: 83-88.
9. Emeis JJ. Perfused rat hindlegs. A model to study plasminogen activator release. Thromb Res 1983; 30: 195-203.
10. Emeis JJ, Brouwer A, Barelds RJ, Horan MA, Durham SK, Kooistra T. On the fibrinolytic system in aged rats, and its reactivity to endotoxin and cytokines. Thromb Haemostas 1992; 67: 679-701.
11. Emeis JJ, Van den Hoogen, Diglio CA. The RHE rat heart endothelial cell line: a model system for studying the synthesis, storage, and acute release of tissue-type plasminogen activator. Thromb Haemostas 1993; 69: 1233.
12. Gallimore MJ, Tyle HM, Shaw JTB. The measurement of fibrinolysis in the rat. Thromb Diath Haemorrh 1971; 26: 279-309.
13. Van Giezen JJJ. Modulation of fibrinolytic activity in rats and other species. PhD thesis. Universiteit Utrecht, The Netherlands, 1993.
14. Van Giezen JJJ, Nenne V, Abrahamsson T. PAI-1 inhibition enhances the lysis of the platelet-rich part of arterial-like thrombi formed in vitro. A comparative study using thrombi prepared from rat and human blood. Blood Coag Fibrinol 1998; 9: 11-18.
15. Ngo TH, Bijnens AP, Knockaert I, Declerck PJ. Expression, purification and characterization of recombinant rat plasminogen activator inhibitor-1. Fibrinolysis 1997; 11: 37-43.
16. Ngo TH, Verheyen S, Knockaert I, Declerck PJ. Monoclonal antibody-based immunoassays for the specific quantitation of rat PAI-1 antigen and activity in biological samples. Thromb Haemostas 1998; 79: 808-812.
17. Galfré F, Milstein C. Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol 1981; 73: 3-46.
18. Debrock S, Declerck PJ. Characterization of common neoantigenic epitopes generated in plasminogen activator inhibitor-1 after cleavage of the reactive center loop or after complex formation with various serine proteinases. FEBS Letters 1995; 376: 243-246.
19. Verheijen JH, Chang GTG, Kluft C. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb Haemostas 1984; 51: 392-395.
20. Emeis JJ, Van Den Hoogen CM. Pharmacological modulation of the endotoxin-induced increase in plasminogen activator inhibitor activity in rats. Blood Coag Fibrinolysis 1992; 3: 575-581.
21. Quax PHA, vanden Hoogen CM, Verheijen JH et al. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. J Biol Chem 1990; 265: 15560-15563.